Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/300401 stock hub

SHE/300401 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300401is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.5B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300401

In the news

Latest news · SHE/300401

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.3

P25 17.1P50 24.2P75 37.8

Trailing P/E32.3

P25 23.5P50 41.3P75 83.2

ROE7.5

P25 -0.9P50 4.1P75 8.8

ROIC7.3

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300401 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

CNY

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,021
Employees Change	78%
Employees Change Percent	8.27
Enterprise value	CNY 7.6B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100001XX7
Last refreshed	2026-05-10
Market cap	CNY 7.5B
Price	CNY 13.84
Price currency	CNY
Rev Per Employee	1,163,457.63x
Sector	Healthcare
Sic	2834
Symbol	she/300401
Website	https://www.hybiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.44%
EV Earnings	29.46x
EV/EBIT	23.94x
EV/EBITDA	15.18x
EV/FCF	38.66x
EV/Sales	6.41x
FCF yield	2.62%
Forward P/E	17.3x
P/B ratio	2.12x
P/E ratio	32.29x
P/S ratio	6.33x
PE Ratio10 Y	44.22x
PE Ratio3 Y	28.66x
PE Ratio5 Y	24.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.8%
EBITDA Margin	42.26%
FCF margin	16.59%
Gross margin	53.16%
Gross Profit	CNY 631.4M
Gross Profit Growth	-11.86%
Gross Profit Growth Q	-27.01%
Gross Profit Growth3 Y	-9.29%
Gross Profit Growth5 Y	8.9%
Net Income	CNY 258.6M
Net Income Growth	-17.7%
Net Income Growth Q	-47.91%
Net Income Growth Years	0%
Net Income Growth3 Y	-3.12%
Net Income Growth5 Y	-2.49%
Pretax Margin	25.06%
Profit Margin	21.77%
Profit Per Employee	CNY 253,305
Profitable Years	18
ROA	3.45
Roa5y	4.84
ROCE	6.68
ROE	7.51
Roe5y	12.39
ROIC	7.33
Roic5y	11.32

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.37%
Cagr1y	-11.23%
Cagr3y	5.33%
Cagr5y	1.56%
Div CAGR3	-15.36%
Div CAGR5	-2.59%
EPS Growth	-21.4
EPS Growth Q	-50
EPS Growth Years	0
EPS Growth3 Y	-5.65
EPS Growth5 Y	-5.25
FCF Growth Q	1,184.42%
OCF Growth	6.19%
OCF Growth Q	38.57%
OCF Growth10 Y	37.21%
OCF Growth3 Y	25.06%
OCF Growth5 Y	3.12%
Revenue Growth	-4.16x
Revenue Growth Q	-15.17x
Revenue Growth Years	0x
Revenue Growth3 Y	-4.13x
Revenue Growth5 Y	11.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.21
Assets	CNY 6B
Cash	CNY 1.6B
Current Assets	CNY 2.6B
Current Liabilities	CNY 1.2B
Debt	CNY 1.7B
Debt EBITDA	CNY 3.45
Debt Equity	CNY 0.49
Debt FCF	CNY 8.8
Equity	CNY 3.5B
Interest Coverage	9.98
Liabilities	CNY 2.5B
Long Term Assets	CNY 3.4B
Long Term Liabilities	CNY 1.2B
Net Cash	CNY -95M
Net Cash By Market Cap	CNY -1.26
Net Debt EBITDA	CNY 0.19
Net Debt Equity	CNY 0.03
Net Debt FCF	CNY 0.48
Tangible Book Value	CNY 3.3B
Tangible Book Value Per Share	CNY 6.11
WACC	5.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.08
Inventory Turnover	0.72
Net Working Capital	CNY 291.7M
Quick ratio	1.43
Working Capital	CNY 1.3B
Working Capital Turnover	CNY 0.93

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.71%
Dividend Growth	60.56%
Dividend Growth Years	1%
Dividend per share	CNY 0.11
Dividend Years	5
Dividend Yield	0.82%
Ex Div Date	2025-04-30
Last Dividend	CNY 0.11
Payout Frequency	Annual
Payout Ratio	37.88%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	39.35%
1Y total return	-11.23%
200-day SMA	15.09
3Y total return	16.87%
50-day SMA	14.61
50-day SMA vs 200-day SMA	50under200
5Y total return	8.07%
All Time High	25.59
All Time High Change	-45.92%
All Time High Date	2018-05-23
All Time Low	1.85
All Time Low Change	648.11%
All Time Low Date	2014-10-09
ATR	0.41
Beta	0.46
Beta1y	0.48
Beta2y	0.36
Ch YTD	-8.47
High	14.05
High52	19.67
High52 Date	2026-02-06
High52ch	-29.64%
Low	13.17
Low52	12.98
Low52 Date	2026-05-07
Low52ch	6.63%
Ma50ch	-5.24%
Price vs 200-day SMA	-8.28%
RSI	50.15
RSI Monthly	48.13
RSI Weekly	43.09
Sharpe ratio	-0.01x
Sortino ratio	0.15
Total Return	-3.9%
Tr YTD	-8.47
Tr1m	-1.56%
Tr1w	5.33%
Tr3m	-27.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 318.3M
Operating Income Growth	-7.66
Operating Income Growth Q	-38.79
Operating Income Growth3 Y	2.29
Operating Income Growth5 Y	4.89
Operating margin	26.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	358,759,307%
Net Borrowing	384,799,722
Shares Insiders	5.13%
Shares Institutions	4.58%
Shares Out	543,685,011
Shares Qo Q	-12.13%
Shares Yo Y	4.71%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 197.1M
Average Volume	12,685,615.2x
Bv Per Share	6.51
CAPEX	CNY -333.2M
Ch10y	31.31
Ch1m	-1.56
Ch1w	5.33
Ch1y	-11.23
Ch3m	-27.73
Ch3y	14
Ch5y	3.13
Change	3.21%
Change From Open	3.21
Close	13.41
Days Gap	0
Depreciation Amortization	183,674,736
Dollar Volume	303,368,149.8
Earnings Date	2026-04-18
EBIT	CNY 318.3M
EBITDA	CNY 502M
EPS	CNY 0.43
F Score	4
FCF	CNY 197.1M
FCF EV Yield	2.59x
FCF Per Share	CNY 0.36
Financing CF	196,828,962
Fiscal Year End	December
Founded	2,000
Graham Number	7.92644
Graham Upside	-42.73
Income Tax	CNY 39M
Investing CF	-339,381,893
Is Primary Listing	1
Last Earnings Date	2026-04-18
Last Report Date	2026-03-31
Last Split Date	2018-05-04
Last Split Type	Forward
Lynch Fair Value	CNY 2.14
Lynch Upside	-84.51
Ma150	14.95
Ma150ch	-7.42%
Ma20	13.64
Ma20ch	1.47%
Net CF	380,589,681
Next Earnings Date	2026-08-14
Open	13.41
P FCF Ratio	38.18
P OCF Ratio	14.19
Payment Date	2025-04-30
Position In Range	76.14
Ppne	3,049,153,454
Price Date	2026-05-08
Price EBITDA	CNY 14.99
Ptbv Ratio	2.26
Relative Volume	1.82x
Revenue	1,187,890,240x
Tax By Revenue	3.29x
Tax Rate	13.12%
Volume	21,919,664
Z Score	3.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300401 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$0.11 annual per share

Payout ratio

+37.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-2.6%

1 consecutive years of growth

Total shareholder yield

-3.9%

Next ex-dividend date: 2025-04-30

Performance

SHE/300401 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300401?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.6%

Share of float held by funds and institutions

Insider ownership

+5.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.7%

Negative means the company is buying back shares.

Technical

SHE/300401 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.2

Neutral momentum band

Price vs 200-day MA

-8.3%

50/200-day relationship not available

Beta (5Y)

0.46

Less volatile than the market

Sharpe ratio

-0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300401

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300401 stock rating?

she/300401 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300401 analysis?

The full report lives at /stocks/she/300401/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300401?

The latest report frames she/300401 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300401 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.